These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 35858357)
1. Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers. Soyama H; Nishio M; Otani J; Sakuma T; Takao S; Hara S; Masuda T; Mimori K; Toyokuni S; Lydon JP; Nakao K; Nishina H; Fukumoto T; Maehama T; Suzuki A Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2123134119. PubMed ID: 35858357 [TBL] [Abstract][Full Text] [Related]
2. The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. Slaninová V; Heron-Milhavet L; Robin M; Jeanson L; Aissanou A; Kantar D; Tosi D; Bréhélin L; Gongora C; Djiane A BMC Cancer; 2024 May; 24(1):587. PubMed ID: 38741073 [TBL] [Abstract][Full Text] [Related]
3. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers. Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856 [TBL] [Abstract][Full Text] [Related]
4. An indispensable role of TAZ in anoikis resistance promoted by OTUB1 deubiquitinating enzyme in basal-like triple-negative breast cancer cells. Nakagawa H; Higurashi M; Ishikawa F; Mori K; Shibanuma M Biochem Biophys Res Commun; 2023 Mar; 649():1-9. PubMed ID: 36738577 [TBL] [Abstract][Full Text] [Related]
7. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells. Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639 [TBL] [Abstract][Full Text] [Related]
8. The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease. Cigliano A; Zhang S; Ribback S; Steinmann S; Sini M; Ament CE; Utpatel K; Song X; Wang J; Pilo MG; Berger F; Wang H; Tao J; Li X; Pes GM; Mancarella S; Giannelli G; Dombrowski F; Evert M; Calvisi DF; Chen X; Evert K J Exp Clin Cancer Res; 2022 Jun; 41(1):192. PubMed ID: 35655220 [TBL] [Abstract][Full Text] [Related]
9. Loss of Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A Development; 2018 Mar; 145(6):. PubMed ID: 29511023 [TBL] [Abstract][Full Text] [Related]
10. The molecular crosstalk of the hippo cascade in breast cancer: A potential central susceptibility. Parambil ST; Antony GR; Littleflower AB; Subhadradevi L Biochimie; 2024 Jul; 222():132-150. PubMed ID: 38494109 [TBL] [Abstract][Full Text] [Related]
11. DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer. Wang D; Li Z; Li X; Yan C; Yang H; Zhuang T; Wang X; Zang Y; Liu Z; Wang T; Jiang R; Su P; Zhu J; Ding Y J Exp Clin Cancer Res; 2022 Jul; 41(1):219. PubMed ID: 35820928 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic Hedgehog-Smoothened Signaling Depends on YAP1‒TAZ/TEAD Transcription to Restrain Differentiation in Basal Cell Carcinoma. Yuan Y; Salinas Parra N; Chen Q; Iglesias-Bartolome R J Invest Dermatol; 2022 Jan; 142(1):65-76.e7. PubMed ID: 34293352 [TBL] [Abstract][Full Text] [Related]
14. Insights into recent findings and clinical application of YAP and TAZ in cancer. Franklin JM; Wu Z; Guan KL Nat Rev Cancer; 2023 Aug; 23(8):512-525. PubMed ID: 37308716 [TBL] [Abstract][Full Text] [Related]
15. Nuclear TAZ expression associates with the triple-negative phenotype in breast cancer. Díaz-Martín J; López-García MÁ; Romero-Pérez L; Atienza-Amores MR; Pecero ML; Castilla MÁ; Biscuola M; Santón A; Palacios J Endocr Relat Cancer; 2015 Jun; 22(3):443-54. PubMed ID: 25870251 [TBL] [Abstract][Full Text] [Related]
16. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis. Li H; Gumbiner BM Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049 [TBL] [Abstract][Full Text] [Related]
17. PI3K Positively Regulates YAP and TAZ in Mammary Tumorigenesis Through Multiple Signaling Pathways. Zhao Y; Montminy T; Azad T; Lightbody E; Hao Y; SenGupta S; Asselin E; Nicol C; Yang X Mol Cancer Res; 2018 Jun; 16(6):1046-1058. PubMed ID: 29545474 [TBL] [Abstract][Full Text] [Related]
18. Advances of targeting the YAP/TAZ-TEAD complex in the hippo pathway for the treatment of cancers. Luo M; Xu Y; Chen H; Wu Y; Pang A; Hu J; Dong X; Che J; Yang H Eur J Med Chem; 2022 Dec; 244():114847. PubMed ID: 36265280 [TBL] [Abstract][Full Text] [Related]
19. Stabilization of Motin family proteins in NF2-deficient cells prevents full activation of YAP/TAZ and rapid tumorigenesis. Wang Y; Zhu Y; Gu Y; Ma M; Wang Y; Qi S; Zeng Y; Zhu R; Wang X; Yu P; Xu J; Shu Y; Yu FX Cell Rep; 2021 Aug; 36(8):109596. PubMed ID: 34433060 [TBL] [Abstract][Full Text] [Related]
20. The Hippo signaling pathway: from multiple signals to the hallmarks of cancers. Zhu N; Yang R; Wang X; Yuan L; Li X; Wei F; Zhang L Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):904-913. PubMed ID: 36942989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]